Novo Nordisk's Ozempic has been shown to improve waking distance and quality of life in people with type 2 diabetes (T2D) and peripheral artery disease (PAD), potentially adding yet another indication ...
2G bands N/A GSM 850 / 900 / 1800 / 1900 - cellular model only 3G bands N/A HSDPA 800 / 850 / 900 / 1700(AWS) / 1900 / 2100 - cellular model only 4G bands N/A 1, 2, 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results